Randomized clinical trial
- Conditions
- chronic kidney disease.Chronic kidney disease, stage 3 (moderate)N18.3
- Registration Number
- IRCT20100223003408N6
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 120
The dosage of medications taken during the past six months did not change during the study
Willing to participate in the study and have written consent
GFR between 15 and 60
Adults between 18-65 years
Has malignancy
AIDS
, acute or inflammatory infection
, diabetes patient
, cancer patients
, decompensated HF patient,
renal transplant recipients
, dialysis patients
, Alzheimer's patients
, patients Cognitive problems,
patients with mental illness
, pregnant patients or those who plan to be pregnant during the study period
, the patient's death during the study
, the patient's unwillingness to participate and participate in training sessions
, the participant with motor impairment (weakness) Musculoskeletal),
treatment regimen over the past month
, loss of inclusion criteria
decline GFR
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EGFR. Timepoint: At the beginning of the study (before the intervention) and six months after the start of treatment and nutrition training. Method of measurement: formula.
- Secondary Outcome Measures
Name Time Method